For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what ...

LONDON — GSK’s once-booming vaccines business met new challenges in the third quarter ... Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. Carina Marquez, MD, associate professor of Medicine in ...

Sales of Pfizer’s new vaccine for respiratory syncytial virus were lower in the third quarter than during the same period last year, but the company pointed to signs of growing market share as reason ...

Two Hamilton-area hospitals are opening clinics this fall for babies to receive a new medicine to prevent respiratory syncytial virus (RSV). Next Monday, the clinics will open in McMaster Children ...

Davis-Standard is a portfolio company of New York-based Gamut Capital Management. Davis-Standard officials are confident in Andrews' ability to lead the company through its next phase of growth ...

African countries face higher costs of financing because of inflated risk perceptions from credit-ratings companies, the head of the continent’s biggest bank said. A United Nations Development ...

Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

Please verify your email address. A recent patch for New World on PC fixes crashes during loading screen transitions. Update 1.1.1 also resolved issues with NPCs and enemies in the game.

GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due to certain underlying medical ...

US pharma major GSK (LSE: GSK) yesterday announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due ...